Friday, August 19, 2022
HomeClimate411“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine

-

The use of Remdesivir for COVID-19 was authorized by the FDA based on a single RCT, conducted by NIAID with the participation of Gilead Sciences, the exclusive manufacturer of Remdesivir. A final report from this study was published on October 8, five months after the drug’s authorization.

- Advertisment -

Related Articles

New Evidence Shows Water Separates into Two Different Liquids at Low Temperatures

Fresh evidence that water can change from one form of liquid into another, denser liquid, has been uncovered by researchers at the University of...

Classical Liberalism and Electricity: An (Unfinished) Exchange with Lynne Kiesling

It is time for fundamental free-market, classical-liberal reform with electricity.”